Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention

<div>(a) sLOX-1 concentrations and 2-year MACCE rate after PCI. (b) Identified risk factors and 2-year MACCE rate after PCI. sLOX-1 = soluble lectin-like oxidized low-density lipoprotein receptor-1, MACCEs = major adverse cardiovascular and cerebrovascular events, PCI = percutaneous coronary intervention.</div>

Disease Markers

fig3

Figure 3

Figure 3: Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention 

Figure 3 | Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention 